Funder
National Natural Science Foundation of China
Fundamental and Applied Basic Research of Guangzhou City-University (Institution) Projects
Science and Technology Program of Guangzhou
Sanming Project of Medicine in Shenzhen Nanshan
Shenzhen Nanshan District Science and Technology Program
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. Andrzejewska A, Lukomska B, Janowski M (2019) Concise review: mesenchymal stem cells: from roots to boost. Stem Cells (Dayton, Ohio) 37:855–864. https://doi.org/10.1002/stem.3016
2. Cabalzar-Wondberg D, Turina M, Biedermann L et al (2021) Allogeneic expanded adipose-derived mesenchymal stem cell therapy for perianal fistulas in Crohn’s disease: a case series. Colorectal Dis Off J Assoc Coloproctol Great Br Irel 23:1444–1450. https://doi.org/10.1111/codi.15587
3. Cheng W, Su J, Hu Y et al (2017) Interleukin-25 primed mesenchymal stem cells achieve better therapeutic effects on dextran sulfate sodium-induced colitis via inhibiting Th17 immune response and inducing T regulatory cell phenotype. Am J Transl Res 9:4149–4160
4. Danese S, Solitano V, Jairath V et al (2022) The future of drug development for inflammatory bowel disease: the need to ACT (advanced combination treatment). Gut 71:2380–2387. https://doi.org/10.1136/gutjnl-2022-327025
5. De Souza HS, Fiocchi C (2016) Immunopathogenesis of IBD: current state of the art. Nat Rev Gastroenterol Hepatol 13:13–27. https://doi.org/10.1038/nrgastro.2015.186